Understanding how disordered regions in genes affect their expression

Uncovering the regulatory logic of gene expression encoded by disordered regions

NIH-funded research Washington University · NIH-10687601

This study is looking at how certain parts of proteins that control gene activity can go wrong and lead to diseases like cancer and brain disorders, helping us understand how our cells work and what happens when things don’t go as they should.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University NIH-funded
Lab location1 site (Saint Louis, United States)
Project IDNIH-10687601 on NIH RePORTER

What this research studies

This research investigates the complex mechanisms that regulate gene expression, particularly focusing on disordered regions of transcription factors that influence how genes are activated or suppressed. By examining these regions, the study aims to uncover how dysregulation can lead to diseases such as cancer and neurodegeneration. The approach involves advanced molecular techniques to analyze the interactions between transcription factors and DNA, providing insights into the fundamental processes that govern cellular function and identity.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals affected by cancers or neurodegenerative diseases linked to gene expression abnormalities.

Not a fit: Patients with conditions unrelated to gene expression dysregulation may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating diseases caused by gene expression dysregulation.

How similar studies have performed: Previous research has shown promising results in understanding gene regulation, but this specific focus on disordered regions is relatively novel.

Where this research is happening

Saint Louis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancersneoplasm/cancer
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.